High Risk High Reward Stocks Based on AI: Returns up to 16.67% in 3 Days

High Risk High Reward Stocks

This forecast is part of the Risk-Conscious Package, as one of I Know First’s equity research solutions. We determine our aggressive stock picks by screening our algorithm daily for higher volatility stocks that present greater opportunities but are also riskier. The full Risk-Conscious Package includes a daily forecast for a total of 40 stocks divided into four main categories:

  • Top 10 Aggressive stocks for the long position
  • Top 10 Aggressive stocks for the short position
  • Top 10 Conservative stocks for the long position
  • Top 10 Conservative stocks for the short position


Package Name: Risk-Conscious – Aggressive Stocks Forecast
Recommended Positions: Long
Forecast Length: 3 Days (03/01/2019 – 03/05/2019)
I Know First Average: 4.09%
High Risk High Reward Stocks

The algorithm correctly predicted 7 out 10 of the suggested trades in the Risk-Conscious – Aggressive Stocks Forecast Package for this 3 Days forecast. CTIC was the highest-earning trade with a return of 16.67% in 3 Days. Additional high returns came from AMRN and NLNK, at 8.94% and 8.88% respectively. The package had an overall average return of 4.09%, providing investors with a 3.90% premium over the S&P 500’s return of 0.19% during the period.

CTI BioPharma Corp. (CTI), incorporated on September 4, 1991, is a biopharmaceutical company focused on the acquisition, development and commercialization of targeted therapies covering a spectrum of blood-related cancers. The Company is primarily focused on commercializing PIXUVRI in select countries in the European Union, for multiply relapsed or refractory aggressive B-cell non-Hodgkin lymphoma (NHL). It is also engaged in evaluating pacritinib for the treatment of adult patients with myelofibrosis. It also evaluates its pipeline candidate paclitaxel poliglumex (Opaxio), which targets solid tumors. It is evaluating Opaxio through cooperative group sponsored trials and investigator-sponsored trials (ISTs), such as the ongoing maintenance therapy trial in patients with ovarian cancer.

Algorithmic traders utilize these daily forecasts by the I Know First market prediction system as a tool to enhance portfolio performance, verify their own analysis and act on market opportunities faster. This forecast was sent to current I Know First subscribers.

How to interpret this diagram

Algorithmic Stock Forecast: The table on the left is a stock forecast produced by I Know First’s algorithm. Each day, subscribers receive forecasts for six different time horizons. Note that the top 10 stocks in the 1-month forecast may be different than those in the 1-year forecast. In the included table, only the relevant stocks have been included. The boxes are arranged according to their respective signal and predictability values (see below for detailed definitions). A green box represents a positive forecast, suggesting a long position, while a red represents a negative forecast, suggesting a short position.

Please note-for trading decisions use the most recent forecast. Get today’s forecast and Top stock picks.